Start-up Flinn has secured $20 million to automate regulatory lifecycle management

While the global healthcare sector is under increasing pressure due to ageing populations and rising costs, the medical device and pharmaceutical industries are being slowed down by increasingly rigid and manual regulatory frameworks.

Founded in 2022 by Markus Müller and Hasib Samad, Flinn offers an AI-powered platform that enables manufacturers to transition from labour-intensive document-based workflows to automated systems capable of handling complex tasks such as safety database monitoring, literature evaluation and vigilance reporting. The platform enables quality and regulatory teams to work more efficiently while ensuring that high-quality healthcare products remain accessible and compliant.

The Vienna-based start-up recently raised $20 million in additional funding, led by HV Capital and with participation from Bertelsmann Healthcare Investments (BHI), as well as existing backers including Cherry Ventures, Speedinvest and SquareOne. This funding will be used for international growth and to accelerate product development.

Sources: Flinn.ai | Crunchbase

Founders: Markus Müller, Hasib Samad